Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,622
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques

Yupeng FengState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;University of Chinese Academy of Sciences100049BeijingChina
,
Chufang LiThe Guangzhou 8th People’s HospitalThe First Affiliated Hospital of Guangzhou Medical University510060GuangzhouChina
,
Peiyu HuState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;The Guangzhou 8th People’s HospitalThe First Affiliated Hospital of Guangzhou Medical University510060GuangzhouChina
,
Qian WangState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;University of Chinese Academy of Sciences100049BeijingChina
,
Xuehua ZhengState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina
,
Yongkun ZhaoKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Institute of Military VeterinaryAcademy of Military Medical Sciences130122ChangchunChina
,
Yi ShiCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of MicrobiologyChinese Academy of Sciences100101BeijingChina
,
Songtao YangKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Institute of Military VeterinaryAcademy of Military Medical Sciences130122ChangchunChina
,
Changhua YiState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina
,
Ying FengThe Guangzhou 8th People’s HospitalThe First Affiliated Hospital of Guangzhou Medical University510060GuangzhouChina
,
Chunxiu WuState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;University of Chinese Academy of Sciences100049BeijingChina
,
Linbing QuState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina
,
Wei XuThe Guangzhou 8th People’s HospitalThe First Affiliated Hospital of Guangzhou Medical University510060GuangzhouChina
,
Yao LiState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;University of Chinese Academy of Sciences100049BeijingChina
,
Caijun SunState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina
,
Fu Geroge GaoState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of MicrobiologyChinese Academy of Sciences100101BeijingChina
,
Xianzhu XiaKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Institute of Military VeterinaryAcademy of Military Medical Sciences130122ChangchunChina
,
Liqiang FengState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChinaCorrespondence[email protected]
&
Ling ChenState Key Laboratory of Respiratory DiseaseGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences510530GuangzhouChina;University of Chinese Academy of Sciences100049BeijingChina;The Guangzhou 8th People’s HospitalThe First Affiliated Hospital of Guangzhou Medical University510060GuangzhouChinaCorrespondence[email protected]
 show all
Pages 1-12 | Received 16 Feb 2018, Accepted 06 May 2018, Published online: 06 Jun 2018

References

  • FeldmannHGeisbertTWEbola haemorrhagic feverLancet2011377 849 86210.1016/S0140-6736(10)60667-83406178
  • FeldmannHJonesSKlenkHDSchnittlerHJEbola virus: from discovery to vaccineNat. Rev. Immunol.2003367768510.1038/nri1154
  • BaizeSEmergence of Zaire Ebola virus disease in GuineaN. Engl. J. Med.20143711418142510.1056/NEJMoa1404505
  • HoelscherMADevelopment of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in miceLancet200636747548110.1016/S0140-6736(06)68076-82762105
  • ZhangYEffects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccineHum. Vaccin. Immunother.2015111803181310.1080/21645515.2015.10421934514253
  • SullivanNJAccelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature200342468168410.1038/nature01876
  • CreechCBRandomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adultsHum. Vaccin. Immunother.201392548255710.4161/hv.260384162066
  • WangHEbola viral glycoprotein bound to its endosomal receptor Niemann-pick C1Cell201616425826810.1016/j.cell.2015.12.044
  • WuSAn adenovirus vaccine expressing Ebola virus variant makona glycoprotein is efficacious in guinea pigs and nonhuman primatesJ. Infect. Dis.2016214S326S33210.1093/infdis/jiw2505050474
  • MilliganIDSafety and immunogenicity of novel adenovirus type 26– and modified vaccinia ankara–vectored ebola vaccines: a randomized clinical trialJAMA20163151610162310.1001/jama.2016.4218
  • TapiaMDUse of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialLancet Infect. Dis.201616314210.1016/S1473-3099(15)00362-X4700389
  • LedgerwoodJEA replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsVaccine20102930431310.1016/j.vaccine.2010.10.037
  • SullivanNJCD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primatesNat. Med.2011171128113110.1038/nm.2447
  • ZhuFCSafety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialLancet201638962162810.1016/S0140-6736(16)32617-4
  • ZhuFCSafety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trialLancet20153852272227910.1016/S0140-6736(15)60553-0
  • XiangZChimpanzee adenovirus antibodies in humans, sub-Saharan AfricaEmerg. Infect. Dis.2006121596159910.3201/eid1210.0600783290939
  • WongGImmune parameters correlate with protection against ebola virus infection in rodents and nonhuman primatesSci. Transl. Med.2012414615810.1186/1479-5876-10-146
  • SullivanNJMartinJEGrahamBSNabelGJCorrelates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNat. Rev. Microbiol.2009739340010.1038/nrmicro2129
  • ChoiJHA single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infectionMol. Pharm.2015122712273110.1021/mp500646d
  • RichardsonJSEnhanced protection against Ebola virus mediated by an improved adenovirus-based vaccinePLoS ONE20094e530810.1371/journal.pone.00053082669164
  • SunCEpidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern ChinaVaccine2011293837384110.1016/j.vaccine.2011.03.042
  • SumidaSMNeutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinJ. Immunol.20051747179718510.4049/jimmunol.174.11.7179
  • ChroboczekJBieberFJacrotBThe sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2Virology199218628028510.1016/0042-6822(92)90082-Z
  • Fernandes, P., Silva, A. C., Coroadinha, A. S. & Alves, P. M. in David T. Curiel Adenoviral Vectors for Gene Therapy (Second Edition) Ch. 6 (Academic Press, San Diego, 2016).
  • LiQNeutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: implications for use of Ad2 vectors in vaccinesHum. Vaccin. Immunother.2017131810.1080/21645515.2017.1278976
  • StanleyDAChimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challengeNat. Med.2014201126112910.1038/nm.3702
  • KonduruKEbola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated miceVaccine2011292968297710.1016/j.vaccine.2011.01.1133070761
  • WarfieldKLEbola virus-like particles protect from lethal Ebola virus infectionProc. Natl Acad. Sci. USA2003100158891589410.1073/pnas.2237038100307663
  • LiWCharacterization of immune responses induced by Ebola virus glycoprotein (GP) and truncated GP isoform DNA vaccines and protection against lethal Ebola virus challenge in miceJ. Infect. Dis.2015212S39840310.1093/infdis/jiv1864564543
  • MarziAVSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strainScience201534973974210.1126/science.aab3920
  • GeisbertTWRecombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against Ebola virus challengeJ. Virol.2011854222423310.1128/JVI.02407-103126236
  • KeshwaraRJohnsonRFSchnellMJToward an effective Ebola virus vaccineAnnu. Rev. Med.20176837138610.1146/annurev-med-051215-030919
  • BarouchDHImmunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityJ. Immunol.20041726290629710.4049/jimmunol.172.10.6290
  • ParksREveleghCGrahamFUse of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administrationGene Ther.199961565157310.1038/sj.gt.3300995
  • ZhangYBergelsonJMAdenovirus receptorsJ. Virol.200579121251213110.1128/JVI.79.19.12125-12131.20051211528
  • ParkDJEbola virus epidemiology, transmission, and evolution during seven months in Sierra LeoneCell20151611516152610.1016/j.cell.2015.06.0074503805
  • Mellquist-RiemenschneiderJLComparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigsVirus Res.20039218719310.1016/S0168-1702(02)00338-6
  • PhoolcharoenWA nonreplicating subunit vaccine protects mice against lethal Ebola virus challengeProc. Natl Acad. Sci. USA2011108206952070010.1073/pnas.11177151083251076
  • WarfieldKLEbola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challengeJ. Infect. Dis.2007196S43043710.1086/520583
  • WarfieldKLInduction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infectionJ. Immunol.20051751184119110.4049/jimmunol.175.2.1184
  • GilbertSCAdenovirus-vectored Ebola vaccinesExpert. Rev. Vaccin.2015141347135710.1586/14760584.2015.1077122
  • XiaoLEnhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in miceHum. Vaccin. Immunother.20131072473310.4161/hv.273404130272
  • ZhengXTreatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infectionSci. Rep.2016610.1038/srep241794828711
  • SunCJMucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeysJ. Virol.2013875669567710.1128/JVI.03247-123648167
  • ZhangQPotent neutralizing monoclonal antibodies against Ebola virus infectionSci. Rep.2016610.1038/srep258564867612
  • ZhengXSeroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern ChinaEmerg. Microbes Infect.2017610.1038/emi.2017.295520307

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.